|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1796582077 |
| 003 |
DE-627 |
| 005 |
20240815163429.0 |
| 007 |
tu |
| 008 |
220324s2021 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1796582077
|
| 035 |
|
|
|a (DE-599)KXP1796582077
|
| 035 |
|
|
|a (OCoLC)1309298022
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 615.7
|q DE-101
|
| 082 |
0 |
4 |
|a 610
|q DE-101
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
1 |
|
|a Uhler, Rico
|d 1990-
|e VerfasserIn
|0 (DE-588)1250311721
|0 (DE-627)1787122158
|4 aut
|
| 245 |
1 |
0 |
|a Glyco-engineered HEK 293-F cell lines to produce therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics
|c vorgelegt von Rico Uhler ; Referent: Prof. Dr. rer. nat. Mathias Hafner
|
| 264 |
|
1 |
|a Heidelberg
|c 2021
|
| 300 |
|
|
|a 143 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-Universität
|d 2021
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in englischer und deutscher Sprache
|
| 650 |
|
4 |
|a Glycobiology
|
| 650 |
|
4 |
|a Biotechnology
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Hafner, Mathias
|d 1956-
|e AkademischeR BetreuerIn
|0 (DE-588)1027781187
|0 (DE-627)729718379
|0 (DE-576)375302956
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Uhler, Rico, 1990 -
|t Glyco-engineered HEK 293-F cell lines to produce therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics
|d Heidelberg, 2022
|h 1 Online-Ressource (143 Seiten)
|w (DE-627)1787121100
|
| 936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|q SEPA
|0 (DE-627)106423304
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20220330
|
| 993 |
|
|
|a Thesis
|
| 998 |
|
|
|g 1250311721
|a Uhler, Rico
|m 1250311721:Uhler, Rico
|d 60000
|d 60001
|e 60000PU1250311721
|e 60001PU1250311721
|k 0/60000/
|k 1/60000/60001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1796582077
|e 4106883104
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"noteThesis":["Dissertation. - Ruprecht-Karls-Universität. - 2021"],"name":{"displayForm":["vorgelegt von Rico Uhler ; Referent: Prof. Dr. rer. nat. Mathias Hafner"]},"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"143 Seiten"}],"title":[{"title":"Glyco-engineered HEK 293-F cell lines to produce therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics","title_sort":"Glyco-engineered HEK 293-F cell lines to produce therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics"}],"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021","publisherPlace":"Heidelberg"}],"id":{"eki":["1796582077"]},"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"recId":"1796582077","person":[{"role":"aut","family":"Uhler","display":"Uhler, Rico","given":"Rico"},{"given":"Mathias","family":"Hafner","display":"Hafner, Mathias","role":"dgs"}],"type":{"bibl":"thesis"}}
|
| SRT |
|
|
|a UHLERRICOGLYCOENGIN2021
|
